Delirium in Older Patients With COVID-19 Presenting to the Emergency Department.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
02 11 2020
02 11 2020
Historique:
entrez:
19
11
2020
pubmed:
20
11
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Delirium is common among older emergency department (ED) patients, is associated with high morbidity and mortality, and frequently goes unrecognized. Anecdotal evidence has described atypical presentations of coronavirus disease 2019 (COVID-19) in older adults; however, the frequency of and outcomes associated with delirium in older ED patients with COVID-19 infection have not been well described. To determine how frequently older adults with COVID-19 present to the ED with delirium and their associated hospital outcomes. This multicenter cohort study was conducted at 7 sites in the US. Participants included consecutive older adults with COVID-19 presenting to the ED on or after March 13, 2020. COVID-19 was diagnosed by positive nasal swab for severe acute respiratory syndrome coronavirus 2 (99% of cases) or classic radiological findings (1% of cases). The primary outcome was delirium as identified from the medical record according to a validated record review approach. A total of 817 older patients with COVID-19 were included, of whom 386 (47%) were male, 493 (62%) were White, 215 (27%) were Black, and 54 (7%) were Hispanic or Latinx. The mean (SD) age of patients was 77.7 (8.2) years. Of included patients, 226 (28%) had delirium at presentation, and delirium was the sixth most common of all presenting symptoms and signs. Among the patients with delirium, 37 (16%) had delirium as a primary symptom and 84 (37%) had no typical COVID-19 symptoms or signs, such as fever or shortness of breath. Factors associated with delirium were age older than 75 years (adjusted relative risk [aRR], 1.51; 95% CI, 1.17-1.95), living in a nursing home or assisted living (aRR, 1.23; 95% CI, 0.98-1.55), prior use of psychoactive medication (aRR, 1.42; 95% CI, 1.11-1.81), vision impairment (aRR, 1.98; 95% CI, 1.54-2.54), hearing impairment (aRR, 1.10; 95% CI 0.78-1.55), stroke (aRR, 1.47; 95% CI, 1.15-1.88), and Parkinson disease (aRR, 1.88; 95% CI, 1.30-2.58). Delirium was associated with intensive care unit stay (aRR, 1.67; 95% CI, 1.30-2.15) and death (aRR, 1.24; 95% CI, 1.00-1.55). In this cohort study of 817 older adults with COVID-19 presenting to US emergency departments, delirium was common and often was seen without other typical symptoms or signs. In addition, delirium was associated with poor hospital outcomes and death. These findings suggest the clinical importance of including delirium on checklists of presenting signs and symptoms of COVID-19 that guide screening, testing, and evaluation.
Identifiants
pubmed: 33211114
pii: 2773106
doi: 10.1001/jamanetworkopen.2020.29540
pmc: PMC7677760
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2029540Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR001862
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG054259
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM107000
Pays : United States
Références
J Am Geriatr Soc. 2014 Mar;62(3):462-9
pubmed: 24512171
Postgrad Med J. 2013 Nov;89(1057):621-5
pubmed: 23788663
Age Ageing. 2020 Jul 1;49(4):497-498
pubmed: 32374367
Age Ageing. 2011 Jul;40(4):412-4
pubmed: 21636556
JAMA. 2017 Sep 26;318(12):1161-1174
pubmed: 28973626
Clin Geriatr Med. 2018 Aug;34(3):299-311
pubmed: 30031418
J Am Geriatr Soc. 2014 Mar;62(3):518-24
pubmed: 24512042
Radiology. 2020 Dec;297(3):E303-E312
pubmed: 32673191
Brain Behav Immun. 2020 Aug;88:68-70
pubmed: 32531427
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Neurology. 2009 May 5;72(18):1570-5
pubmed: 19414723
J Am Geriatr Soc. 2009 May;57(5):889-94
pubmed: 19484845
J Med Virol. 2020 Apr 15;:
pubmed: 32293716
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774
J Clin Neurosci. 2020 Jul;77:8-12
pubmed: 32409215
MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):904-908
pubmed: 32673296
PLoS One. 2014 Nov 04;9(11):e111823
pubmed: 25369057
Ann Clin Transl Neurol. 2020 May 20;:
pubmed: 32433817
N Engl J Med. 1999 Mar 4;340(9):669-76
pubmed: 10053175
Infect Dis Clin North Am. 2017 Dec;31(4):593-608
pubmed: 29079150
Crit Care Clin. 2017 Apr;33(2):225-243
pubmed: 28284292
Age Ageing. 2020 Jul 1;49(4):523-524
pubmed: 32315386
Arch Intern Med. 2012 Sep 24;172(17):1324-31
pubmed: 23403619
Brain. 2012 Sep;135(Pt 9):2809-16
pubmed: 22879644
Gen Hosp Psychiatry. 2020 Jul - Aug;65:47-53
pubmed: 32470824
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Ann Intern Med. 2012 Jun 19;156(12):848-56, W296
pubmed: 22711077
J Am Geriatr Soc. 2005 Feb;53(2):312-8
pubmed: 15673358
Emerg Med J. 2013 Apr;30(4):263-8
pubmed: 22833596
J Am Geriatr Soc. 2020 Jul;68(7):1382-1384
pubmed: 32383778
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
BMJ. 2020 May 22;369:m1985
pubmed: 32444460
J Am Geriatr Soc. 2020 Aug 24;:
pubmed: 32835425